NCT02918461View on ClinicalTrials.gov

Emerging From the Haze for Gynecologic Cancer Survivors

NACompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

January 10, 2017

Primary Completion Date

May 31, 2017

Study Completion Date

November 30, 2017

Conditions
Gynecologic NeoplasmsCognition Disorders
Interventions
BEHAVIORAL

Emerging from the Haze class

A 6-week class designed to combat chemotherapy-induced cognitive dysfunction. Patients will report symptoms at 6 months and 1 year after the end of their Haze class.

Trial Locations (1)

90048

Cedars Sinai Medical Center, Los Angeles

All Listed Sponsors
lead

Cedars-Sinai Medical Center

OTHER

NCT02918461 - Emerging From the Haze for Gynecologic Cancer Survivors | Biotech Hunter | Biotech Hunter